Germline Testing for Predisposition to Myeloid Malignancies

Clinical trial NCT07112287 · RECRUITING

Trial details

NCT number: NCT07112287
Sponsor: Christopher Reilly
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Myeloid Malignancy Genetic Predisposition to Disease Myeloid Hematological Malignancies

Start date: 2025-11-10
Primary completion: 2030-04-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.